Cytomegalovirus affects clinical outcome of infliximab in ulcerative colitis refractory to tacrolimus
- PMID: 20636704
- DOI: 10.1111/j.1365-2036.2010.04372.x
Cytomegalovirus affects clinical outcome of infliximab in ulcerative colitis refractory to tacrolimus
Comment on
-
Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus.Aliment Pharmacol Ther. 2010 May;31(9):1036-41. doi: 10.1111/j.1365-2036.2010.04267.x. Epub 2010 Feb 18. Aliment Pharmacol Ther. 2010. PMID: 20175769
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical